Russian Federation
Vladivostok, Vladivostok, Russian Federation
Russian Federation
. M. Sechenov First Moscow State Medical University (kafedra epidemiologii i sovremennyh tehnologiy vakcinacii, Professor of Department)
Moscow, Russian Federation
The paper presents the results of the study of cytokines, chemokines and growth factors in the sera of HIV-infected patients by the method of multiplex analysis. Differences of some indicators and particularities of correlation profile are defined depending on the presence or absence of viremia.
HIV, cytokine status, multiplex analysis, diagnostics
1. Musa F., Shaviya N., Mambo F. et al. Cytokine profiles in highly active antiretroviral treatment non-adherent, adherent and naive HIV-1 infected patients in Western Kenya // African health sciences. – 2021, 21(4), 1584–1592. Doi /10.4314/ahs.v21i4.12
2. Catalfamo M., Le Saout C., Lane H.C. The role of cytokines in the pathogenesis and treatment of HIV infection. Cytokine Growth Factor Rev. 2012, 23(4–5), 207-214. Doi 10.1016/ j.cytogfr.2012.05.007
3. Bordoni V., Sacchi A., Casetti R. et al. Impact of ART on dynamics of growth factors and cytokines in primary HIV infection. Cytokine. 2020, 125, 154839. Doihttps://doi.org/10.1016/j.cyto.2019.154839
4. Lokau J., Petasch L.M., Garbers C. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function // Immunology. – 2024. – 171(3). – 377–387. Doihttps://doi.org/10.1111/imm.13723
5. Muhammad S., Fan T., Hai Y., Gao Y., He J. Reigniting hope in cancer treatment: the promise and pitfalls of IL–2 and IL–2R targeting strategies // Mol Cancer. – 2023. – 22(1). 121. Doi:https://doi.org/10.1186/s12943-023-01826-7
6. Pananghat A.N., Aggarwal H., Prakash S.S. et al. IL-8 Alterations in HIV-1 infected children with disease progression // Medicine (Baltimore). – 2016. – 95(21). Doi: 10.1097/ MD.0000000000003734
7. Ellwanger J.H., Valverde-Villegas J.M., Kaminski V.L. et al. Increased IL-8 levels in HIVinfected individuals who initiated ART with CD4+ T cell counts <350 cells/mm3 - A potential hallmark of chronic inflammation // Microbes Infect. – 2020. – 22(9). – 474-480. Doi: 10.1016/ j.micinf.2020.05.019
8. Monteiro de Almeida S., Letendre S., Zimmerman J. et al. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma // J Neuroimmunol. – 2005. – 169(1-2). – 144-152. Doi:https://doi.org/10.1016/j.jneuroim.2005.07.012
9. Gonzalez E., Rovin B.H., Sen L. et al. HIV–1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP–1 levels // Proc Natl Acad Sci USA. – 2002. 99(21). – 13795–13800. Doi:https://doi.org/10.1073/pnas.202357499
10. Poveda E., Fitzgerald W., Alonso-Domínguez J. et al. Elevated plasma levels of IP–10 and MIG are early predictors of loss of control among elite HIV controllers // Front Immunol. – 2024. – 15. – 1446730. Doi:https://doi.org/10.3389/fimmu.2024.1446730
11. Álvarez H., Gutiérrez-Valencia A., Mariño A. et al. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors // Front Immunol. – 2023. – 14. – 1257725. Doi:https://doi.org/10.3389/fimmu.2023.1257725
12. Roff S.R., Noon-Song E.N., Yamamoto J.K. The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy and Prophylaxis // Front Immunol. – 2014. – 4. – 498. Doi: 10.3389/ fimmu.2013.00498
